A Novel Role for p120 Catenin in E-Cadherin Function
Ireton, Reneé C., Davis, Michael A., van Hengel, Jolanda, Mariner, Deborah J., Barnes, Kirk, Thoreson, Molly A., Anastasiadis, Panos Z., Matrisian, Linsey, Bundy, Linda M., Sealy, Linda, Gilbert, Barbara, van Roy, Frans, Reynolds, Albert B.
Published in The Journal of cell biology (11.11.2002)
Published in The Journal of cell biology (11.11.2002)
Get full text
Journal Article
Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
Spigel, David R, Bendell, Johanna C, McCleod, Michael, Shipley, Dianna L, Arrowsmith, Edward, Barnes, E. Kirk, Infante, Jeffrey R, Burris, Howard A, Greco, F. Anthony, Hainsworth, John D
Published in Clinical colorectal cancer (01.03.2012)
Published in Clinical colorectal cancer (01.03.2012)
Get full text
Journal Article
A phase II trial of mFOLFOX-bevacizumab (bev) followed by single-agent axitinib (ax) as maintenance therapy for patients (pts) with first-line metastatic colorectal cancer (mCRC)
Joseph, Mathew John, Barnes, Kirk, Blachly, Ronald, Kuzur, Michel E., Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer
Bendell, Johanna C., Joseph, Mathew, Barnes, Kirk, Mainwaring, Mark, Shipley, Dianna, Reddy, Chandra, Blakely, Laura, Blachly, Ronald, Lane, Cassie M., Earwood, Chris, Kuzur, Michel
Published in Cancer investigation (03.07.2017)
Published in Cancer investigation (03.07.2017)
Get full text
Journal Article